Recommendations for Obtaining a Labeling Claim for Communicable Disease Donor Screening Tests Using Cadaveric Blood Specimens from Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps): Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
November 1, 2004
May 8, 2024
2565c7c9-cea3-4b8f-b6bd-75572e27c93d
Related Documents
Compliance with 21 CFR Part 1271150(c)(1) – Manufacturing Arrangements: Guidance for Industry
Guidance DocumentSeptember 8, 2006Center for Biologics Evaluation and Research
FDA Review of Vaccine Labeling Requirements for Warnings, Use Instructions, and Precautionary Information: Guidance for Industry
Guidance DocumentOctober 1, 2004Center for Biologics Evaluation and Research
Certain Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) Recovered from Donors Who Were Tested for Communicable Diseases Using Pooled Specimens or Diagnostic Tests: Guidance for Industry
Guidance DocumentApril 16, 2008Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.